Approval · Notice of Compliance 20221 · 2017
PAYLEAN 100: Notice of Compliance 20221
Issued December 14, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20221
- Date
- December 14, 2017
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAYLEAN 100 | 02268965 | Cancelled Pre Market |
Medicinal ingredients
- RACTOPAMINE HCL 100 G per KG